ADAM-12 exhibits catalytic activity by cleaving certain ligands that are biologically important for tumour growth, such as tumour necrosis factor-alpha (TNF-α), epidermal growth factor (EGF), and transforming growth factor-alpha (TGF-α) [17, 18]. This evidence concerns the gene TGFA and neoplasm.